M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Gyre Therapeutics, Inc. to acquire Cullgen
Announced Mar 2, 2026 · Closed May 4, 2026 · Private target
Deal value$300M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Gyre Therapeutics, Inc. (GYRE)
- Target
- Cullgen
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed May 4, 2026
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Moelis
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations